Low dose inhaled LPS challenge – Reproducibility of the inflammatory response

O. Holz, F. Schaumann, O. Janssen, B. Lavae-Mokhtari, H. Biller, N. Krug, J.M. Hohlfeld (Hanover, Germany)

Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Session: Translational respiratory medicine in asthma and COPD
Session type: Thematic Poster Session
Number: 2185
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Holz, F. Schaumann, O. Janssen, B. Lavae-Mokhtari, H. Biller, N. Krug, J.M. Hohlfeld (Hanover, Germany). Low dose inhaled LPS challenge – Reproducibility of the inflammatory response. Eur Respir J 2012; 40: Suppl. 56, 2185

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012



Lung-epithelial C/EBPβ plays a role in the effects of budesonide and formoterol on the inflammatory response to LPS in vivo
Source: Annual Congress 2010 - Models of airways disease
Year: 2010

Bacterial endotoxin-induced T-lymphocyte immune response is impaired in COPD – effect of moxifloxacin and dexamethasone
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009

The failure rate of sputum induction following inhaled lipopolysaccharide (LPS) challenge in healthy subjects
Source: Annual Congress 2008 - COPD: from bench to bedside
Year: 2008


Effect of montelucast (Singulair®) on bronchial and nasal reactivity induced by allergen challenge
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009

Relationships of mannitol challenge to methacholine challenge and inflammatory markers in asthmatics receiving inhaled corticosteroids
Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease
Year: 2012



Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Treatment of patients with uncontrolled asthma using high dose inhaled corticosteroids administered by controlled inhalation – a retrospective analysis
Source: Annual Congress 2009 - Aspects of uncontrolled asthma
Year: 2009


Resistin like molecule β is upregulated in human respiratory epithelium following repeated inhaled allergen challenge
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009

Influence of formoterol alone and its fixed combination with budesonide on airway responsiveness and airway inflammation induced by repeated low dose allergen challenge
Source: Eur Respir J 2007; 30: Suppl. 51, 749s
Year: 2007

LATE-BREAKING ABSTRACT: Effect of inhaled kinase inhibitor on airway inflammation assessed in induced sputum after challenge with inhaled lipopolysaccharide
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016


Inhaled LPS challenge in healthy subjects: a dose escalation study
Source: International Congress 2018 – Studies on the mechanisms underlying airway disease
Year: 2018

Respiratory impedance response to a deep inhalation (DI) in children during methacholine (MCh) challenge
Source: Eur Respir J 2001; 18: Suppl. 33, 347s
Year: 2001

Effects of Bu-Zhong-Yi-Qi-Tang (Hochuekkito; TJ-41) on the inflammatory responses in alveolar macrophages of hyperglycemic mice
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011

Mechanism of protective effect of inhaled budesonide on airway response to ozone (O3) exposure
Source: Eur Respir J 2004; 24: Suppl. 48, 364s
Year: 2004

Plasma and urinary concentrations of inhaled salmeterol in healthy and persons with asthma – Quantifying a doping limit
Source: Annual Congress 2011 - Asthma management and response
Year: 2011

Optimization of inhalation treatment – Assessment of the influence of diluent and air humidity on particle distribution of colistin administered by BCTS method [bronchial control treatment system]
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010


Effects of low dose inhaled theophylline (ADC4022) co-administered with budesonide on inflammatory markers, lung function, and quality of life in COPD patients
Source: Annual Congress 2009 - New drugs for airways disease
Year: 2009


Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma
Source: Annual Congress 2008 - Cough and airway hyperresponsiveness
Year: 2008

Effect of IgE sensitization and allergen exposure on exhaled NO during inhaled corticosteroid (ICS) treatment in patients with asthma
Source: Annual Congress 2007 - Primary care respiratory problems
Year: 2007